XMRV is Present in Malignant Prostatic Epithelium and is Associated with Prostate Cancer, Especially High-grade Tumors

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2009 Oct 7

PMID 19805305

Citations 162

Authors

Robert Schlaberg

Daniel J Choe

Kristy R Brown

Harshwardhan M Thaker

Ila R Singh

Affiliations

Soon will be listed here.

Abstract

Xenotropic murine leukemia virus-related virus (XMRV) was recently discovered in human prostate cancers and is the first gammaretrovirus known to infect humans. While gammaretroviruses have well-characterized oncogenic effects in animals, they have not been shown to cause human cancers. We provide experimental evidence that XMRV is indeed a gammaretrovirus with protein composition and particle ultrastructure highly similar to Moloney murine leukemia virus (MoMLV), another gammaretrovirus. We analyzed 334 consecutive prostate resection specimens, using a quantitative PCR assay and immunohistochemistry (IHC) with an anti-XMRV specific antiserum. We found XMRV DNA in 6% and XMRV protein expression in 23% of prostate cancers. XMRV proteins were expressed primarily in malignant epithelial cells, suggesting that retroviral infection may be directly linked to tumorigenesis. XMRV infection was associated with prostate cancer, especially higher-grade cancers. We found XMRV infection to be independent of a common polymorphism in the RNASEL gene, unlike results previously reported. This finding increases the population at risk for XMRV infection from only those homozygous for the RNASEL variant to all individuals. Our observations provide evidence for an association of XMRV with malignant cells and with more aggressive tumors.

Citing Articles

Definition of emerging infectious diseases.

Laperche S ISBT Sci Ser. 2020; 6(1):112-115.

PMID: 32328166 PMC: 7169259. DOI: 10.1111/j.1751-2824.2011.01452.x.

Male circumcision and prostate cancer: A geographical analysis, meta-analysis, and cost analysis.

Van Howe R Can Urol Assoc J. 2020; 14(7):E334-E340.

PMID: 32017694 PMC: 7337715. DOI: 10.5489/cuaj.6126.

Epidemiology of Prostate Cancer.

Rawla P World J Oncol. 2019; 10(2):63-89.

PMID: 31068988 PMC: 6497009. DOI: 10.14740/wjon1191.

If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease.

Sfanos K, Yegnasubramanian S, Nelson W, Lotan T, Kulac I, Hicks J Asian J Urol. 2019; 6(1):10-25.

PMID: 30775245 PMC: 6363603. DOI: 10.1016/j.ajur.2018.11.006.

Ductal variant of prostate adenocarcinoma harbor Xenotropic murine leukemia virus related virus (XMRV) infection: a novel finding in subtype of prostate cancer.

Ahmed Baig F, Mirza T, Hamid A, Syed S, Jamal Q Turk J Urol. 2017; 43(3):268-272.

PMID: 28861296 PMC: 5562243. DOI: 10.5152/tud.2017.85451.

References

Parkin D, Bray F, Devesa S . Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001; 37 Suppl 8:S4-66. DOI: 10.1016/s0959-8049(01)00267-2. View

Andriole G, Crawford E, Grubb 3rd R, Buys S, Chia D, Church T . Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360(13):1310-9. PMC: 2944770. DOI: 10.1056/NEJMoa0810696. View

Schroder F, Hugosson J, Roobol M, Tammela T, Ciatto S, Nelen V . Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13):1320-8. DOI: 10.1056/NEJMoa0810084. View

Payne G, Courtneidge S, Crittenden L, Fadly A, Bishop J, Varmus H . Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state. Cell. 1981; 23(2):311-22. DOI: 10.1016/0092-8674(81)90127-6. View

Matsuoka M, Jeang K . Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007; 7(4):270-80. DOI: 10.1038/nrc2111. View

Hayat M, Howlader N, Reichman M, Edwards B . Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007; 12(1):20-37. DOI: 10.1634/theoncologist.12-1-20. View

Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein E . An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A. 2007; 104(5):1655-60. PMC: 1776164. DOI: 10.1073/pnas.0610291104. View

Telesnitsky A, Blain S, Goff S . Assays for retroviral reverse transcriptase. Methods Enzymol. 1995; 262:347-62. DOI: 10.1016/0076-6879(95)62029-x. View

Yeager M, WEINER S, Brown P, Rein A . Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A. 1998; 95(13):7299-304. PMC: 22596. DOI: 10.1073/pnas.95.13.7299. View

10.

De Marzo A, Platz E, Sutcliffe S, Xu J, Gronberg H, Drake C . Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007; 7(4):256-69. PMC: 3552388. DOI: 10.1038/nrc2090. View

11.

Hayes R, Pottern L, STRICKLER H, Rabkin C, Pope V, Swanson G . Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer. 2000; 82(3):718-25. PMC: 2363322. DOI: 10.1054/bjoc.1999.0986. View

12.

Yuan B, Li X, Goff S . Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 1999; 18(17):4700-10. PMC: 1171543. DOI: 10.1093/emboj/18.17.4700. View

13.

Urisman A, Molinaro R, Fischer N, Plummer S, Casey G, Klein E . Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006; 2(3):e25. PMC: 1434790. DOI: 10.1371/journal.ppat.0020025. View

14.

Fischer N, Hellwinkel O, Schulz C, Chun F, Huland H, Aepfelbacher M . Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol. 2008; 43(3):277-83. DOI: 10.1016/j.jcv.2008.04.016. View

15.

Auerbach M, Brown K, Singh I . Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein. J Virol. 2007; 81(22):12337-47. PMC: 2168981. DOI: 10.1128/JVI.01286-07. View

16.

Cousens C, Maeda N, Murgia C, Dagleish M, Palmarini M, Fan H . In vivo tumorigenesis by Jaagsiekte sheep retrovirus (JSRV) requires Y590 in Env TM, but not full-length orfX open reading frame. Virology. 2007; 367(2):413-21. PMC: 2065845. DOI: 10.1016/j.virol.2007.06.004. View

17.

Grassmann R, Aboud M, Jeang K . Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005; 24(39):5976-85. DOI: 10.1038/sj.onc.1208978. View

18.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

19.

Casey G, Neville P, Plummer S, Xiang Y, Krumroy L, Klein E . RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002; 32(4):581-3. DOI: 10.1038/ng1021. View

20.

Kim S, Kim N, Dong B, Boren D, Lee S, Das Gupta J . Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol. 2008; 82(20):9964-77. PMC: 2566297. DOI: 10.1128/JVI.01299-08. View